Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.370
+0.170 (7.73%)
At close: Dec 20, 2024, 4:00 PM
2.380
+0.010 (0.42%)
After-hours: Dec 20, 2024, 6:43 PM EST
Nkarta Market Cap
Nkarta has a market cap or net worth of $167.25 million as of December 20, 2024. Its market cap has increased by 23.04% in one year.
Market Cap
167.25M
Enterprise Value
-30.36M
1-Year Change
23.04%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $167.25M, a decrease of -88.58%. That is a compound annual growth rate of -38.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 167.25M | -48.36% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | 2.00B | 36.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 171.08M |
| scPharmaceuticals | 169.64M |
| Innate Pharma | 168.93M |
| TScan Therapeutics | 167.82M |
| Elutia | 167.28M |
| Solid Biosciences | 166.21M |
| Fennec Pharmaceuticals | 164.29M |
| Caribou Biosciences | 162.99M |